This stock forecast draws from 17 individual, firm-attributed analyst targets gathered from brokerage research, TipRanks, MarketBeat, and related coverage. The targets span roughly $315 to $450, and the arithmetic mean of the set is about $367, rounded to a clean $370 for the headline.
The analyst consensus leans positive but is not unanimous. More firms carry Buy or Outperform ratings than Hold ratings, while BTIG stands out with a Sell rating and a $315 target. Recent revisions illustrate the dispersion: J.P. Morgan held a $365 Buy target in late October, Morgan Stanley and BMO Capital both sit at $380, Wells Fargo at $415, RBC Capital at $400, and Deutsche Bank at $450, while Citi ($335), TD Cowen ($335), Evercore ISI ($330), and Monness ($320) remain more cautious. Several targets were trimmed in September and October even as some were raised after third-quarter results, reflecting genuine disagreement about how much the company's earnings growth justifies a richer multiple. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
American Express closed near $320.99 on its most recent session, giving it a market capitalization of about $215 billion and a trailing P/E near 18. Reaching the $370 central target would require a gain of roughly 15.3%, a substantial but not extreme move for a large-cap financial.
In its third quarter, the company reported record revenue of about $20.1 billion, up 9% year over year, with adjusted EPS of $4.68, up 13%. Management reaffirmed its 10% revenue-growth outlook and raised full-year EPS guidance to $18.30–$18.60 (reported) or $17.60–$17.90 (adjusted). Analysts note that the forward P/E has returned to roughly 17 times, right at its 10-year average, which means further upside now depends heavily on continued earnings growth rather than multiple expansion.
American Express trades well below its 52-week high of $387.49 and above its 52-week low of $290.97. After a November rally, the stock briefly touched about $343.89 before pulling back, leaving a resistance level near $345–$350 and a further barrier near the prior high around $387. On the downside, the psychologically important $300 area and the $290.97 low serve as key support level zones. A sustained move toward $370 would require clearing the $345–$350 band, which currently sits just above the latest close.
Most analyst price targets reflect a research horizon of roughly 12 months, though individual firms apply different models and assumptions. The next major catalyst is the fourth-quarter earnings report, tentatively scheduled for late January, which will carry the first 2027 guidance. Investors should watch card-spending and write-off trends, net card-fee growth, any further analyst revisions, executive insider activity, and macroeconomic signals such as consumer confidence and Federal Reserve rate decisions, all of which could shift the market outlook for AXP. From what I see, this is important because it highlights how earnings delivery will drive the next leg higher.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, keep watch over existing positions, and spot shifting trends more efficiently than manual screening. As you evaluate whether AXP can reach its $370 target, the AI Daily Buy/Sell Signals offer an automated way to stay current on evolving momentum. I’m watching this closely as part of my regular process for stocks like this one.
Whether American Express can reach $370 depends on sustaining the mid-teens EPS growth its current valuation already reflects. The $370 figure is a calculated average of 17 analyst targets spanning a very wide $315-to-$450 range, not a guarantee. Support comes from raised guidance, double-digit fee growth, and stable credit, while a full multiple, insider selling, and consumer-cycle risk represent the principal obstacles. With the next earnings report likely in late January, analyst revisions and credit metrics are the clearest signals to watch before drawing conclusions about the path toward this average analyst price target.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
AXP moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 36 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 72%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on AXP as a result. In 48 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for AXP just turned positive on October 06, 2026. Looking at past instances where AXP's MACD turned positive, the stock continued to rise in 30 of 44 cases over the following month. The odds of a continued upward trend are 68%.
The 10-day moving average for AXP crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +3.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXP advanced for three days, in 204 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 174 of 282 cases where AXP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The 10-day RSI Indicator for AXP moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 26 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 64 cases where AXP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
AXP broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 4 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating steady price growth. AXP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.323) is normal, around the industry mean (3.902). P/E Ratio (19.442) is within average values for comparable stocks, (6.401). Projected Growth (PEG Ratio) (1.232) is also within normal values, averaging (3.918). Dividend Yield (0.012) settles around the average of (0.189) among similar stocks. P/S Ratio (2.824) is also within normal values, averaging (5.901).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a financial conglomerate
Industry SavingsBanks